Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.
This report contains market size and forecasts of Monkeypox Vaccine in global, including the following market information:
Global Monkeypox Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Monkeypox Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Monkeypox Vaccine companies in 2021 (%)
The global Monkeypox Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Monkeypox Vaccine include Bavarian Nordic inks, Emergent BioSolutions and SIGA Technologies, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Monkeypox Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monkeypox Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Monkeypox Vaccine Market Segment Percentages, by Type, 2021 (%)
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Global Monkeypox Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Monkeypox Vaccine Market Segment Percentages, by Application, 2021 (%)
Aldult
Child
Global Monkeypox Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Monkeypox Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monkeypox Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Monkeypox Vaccine revenues share in global market, 2021 (%)
Key companies Monkeypox Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Monkeypox Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bavarian Nordic inks
Emergent BioSolutions
SIGA Technologies, Inc.